Abstract:ID 93978 Poster Board 520 Altered dopamine signaling in the central nervous system (CNS) has been the subject of many studies, as it has become a fundamental feature of numerous CNS diseases and disorders, including Parkinson's disease (PD) and substance use disorder (SUD). The dopamine transporter (DAT) is the primary regulator of dopamine (DA) signaling in the central nervous system (CNS) and in the periphery. This member of the re-uptake-1 monoamine transporters (MATs) clears extracellular dopamine by transporting it into the cell for storage. Recent studies have shown that peripheral immune cells such as monocytes and macrophages express DAT and the norepinephrine transporter (NET), and that DAT regulates innate immune response. Alterations of DAT in the CNS impacts the expression of this protein in peripheral immune cells affecting immune regulation. Development of methodologies and tools that will facilitate our understanding of the mechanism underlying these observations can facilitate strategies to study DAT-associated disease and disorders in the periphery. Fluorescently labelled ligands (FLL) have proven useful as tools to study protein expression, localization, and distribution and downstream processes in distinct live cell systems, opening a venue to study endogenously expressed proteins. In this work, we set out to develop a high affinity and selective FLL for the detection of DAT in peripheral blood mononuclear cells (PBMCs) by flow cytometry. For our synthetic design, we identified two atypical DAT inhibitors, JJC8-087 and JJC8-089, as parent ligands. These compounds bind with high affinity to DAT and selectivity over SERT and NET. Fluorescent labelling of the parent ligand was based on previously reported structure-activity relationship studies. Binding affinities of all final compounds for rDAT, rSERT and rNET were obtained via radioligand binding assay in Sprague-Dawley rat brain tissue and hDAT-HEK293 cell membranes. PBMCs were isolated from whole blood via density media centrifugation and samples treated with either the FLL or a control antibody were analyzed via flow cytometry on a 5-laser Cytek Aurora Spectral Cytometer. Probes based on JJC8-087 demonstrated the highest DAT affinity and were selective with respect to SERT and NET. The lead DiSulfoCy5 FLL, GC04-38 (rDAT K i = 159 nM) was ~26-fold rDAT selective over rSERT ( K i = 4.2 mM) and >63-fold selective over rNET ( K i = >10 mM), in addition, a similar binding affinity for hDAT was obtained ( K i = 191 nM). GC04-38 was used to label DAT in both mouse and human peripheral blood mononuclear cells (PBMCs) and analyzed via flow cytometry revealing comparable results with a control DAT antibody, reducing the time of sample preparation from 165 minutes (antibody control) to 30 min (FLL). We validated the selective detection of DAT with PBMCs isolated from a DAT knockout mouse demonstrating high specificity of this FLL. Overall, our results suggest a robust use for this novel FLL probe to increase our understanding of CNS-peripheral DAT regulation mechanisms underlying health and disease. This research is funded by the National Institutes of Health (NIH) – National Institute on Drug Abuse (NIDA) - Intramural Research Program.

Identification of DAT1/LIM2-interacting Proteins by Yeast Two-Hybrid Screening

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

Identification of novel proteins interacting with both α-synuclein and DJ-1

Screen and identification of proteins interacting with ADAM19 cytoplasmic tail

Screening of Proteins Interacting with CUEDC2 by Yeast Two Hybrid

Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking

Regulation of Dopamine Transporter Activity by Carboxypeptidase E

Interaction of Stathmin-Like 2 Protein with the APP Intracellular Domain

Identification of COMMD1 As a Novel Lamin A Binding Partner

Dimerization of hub protein DYNLL1 and bZIP transcription factor CREB3L1 enhances transcriptional activation of CREB3L1 target genes like arginine vasopressin

Identification of a novel human doublecortin-domain-containing gene ( DCDC1 ) expressed mainly in testis

Screening of Proteins Interacting with Dishevelled2 in Mouse 11.5dpc Embryo Library

Identification of Hepatopoietin Interacting Proteins in Human Testis by Yeast Two-Hybrid System

A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth

Fluorescently Labelled Ligand Allow Detection of DAT in Human and Mouse Peripheral Blood Monocytes by Flow Cytometry

Yeast Two-Hybrid Screening for Proteins That Interact with Alpha(1)-Adrenergic Receptors

Identification of TCP10L As Primate-Specific Gene Derived Via Segmental Duplication and Homodimerization of TCP10L Through the Leucine Zipper Motif

Functional enrichment analysis of three Alzheimer's disease genome-wide association studies identities DAB1 as a novel candidate liability/protective gene

Identification of a Human LNX Protein Containing Multiple PDZ Domains

Effects of the dopamine transporter gene on striatal functional connectivity in youths with attention-deficit/hyperactivity disorder

Construction and screening of suppression subtractive hybridization library of Down's syndrome